Search Results - "Lutterbeck, M."

Long-term stimulation of Toll-like receptor 3 in primary human hepatocytes leads to sensitization for antiviral responses induced by poly I:C treatment by Broering, R., Lutterbeck, M., Trippler, M., Kleinehr, K., Poggenpohl, L., Paul, A., Gerken, G., Schlaak, J. F.

“…Summary Chronic hepatitis C infection is associated with increased expression of interferon‐sensitive genes (ISGs) in the liver, which is, paradoxically,…”
Get full text

P0705 : Antiviral activity of human non-parenchymal liver cells is restricted to toll-like receptor 3 and involves type I interferons by Lutterbeck, M, Driftmann, S, Kleinehr, K, Paul, A, Gerken, G, Schlaak, J.F, Broering, R

Get full text

P218 TOLL-LIKE RECEPTOR 3 STIMULATION OF HUMAN NON-PARENCHYMAL LIVER CELLS TRIGGERS AN ANTIVIRAL STATE AGAINST HCV WHICH IS NOT EXCLUSIVELY MEDIATED BY TYPE-I OR TYPE-III IFNS by Lutterbeck, M, Broering, R, Kleinehr, K, Paul, A, Gerken, G, Schlaak, J.F

Get full text

347 REPETITIVE ACTIVATION OF TOLL-LIKE RECEPTOR 3 IN PRIMARY HUMAN HEPATOCYTES LEADS TO HYPER-RESPONSIVENESS TO POLY I:C IN VITRO by Broering, R, Lutterbeck, M, Trippler, M, Paul, A, Kleinehr, K, Gerken, G, Schlaak, J.F

Get full text

P150 INTERFERON-STIMULATED GENE 15, A PROVIRAL FACTOR FOR HEPATITIS C VIRUS, AND PROTEASOME SUBUNIT ALPHA TYPE-6 ARE INDUCED BY POLY(I:C) AND RECIPROCALLY AFFECT EACH OTHER by Broering, R, Trippler, M, Lutterbeck, M, Real, C.I, Kleinehr, K, Poggenpohl, L, Gerken, G, Schlaak, J.F

Get full text

P0696 : Proteasome subunit alpha type-6 regulates the expression of proviral host genes in hepatitis C virus infection by Broering, R, Trippler, M, Lutterbeck, M, Real, C.I, Megger, D.A, Bracht, T, Schweinsberg, V, Sitek, B, Eisenacher, M, Meyer, H.E, Baba, H.A, Weber, F, Hoffmann, A.-C, Gerken, G, Schlaak, J.F

Get full text

128 TOLL-LIKE RECEPTOR-ACTIVATED HUMAN HEPATOCYTES PRODUCE INFLAMMATORY CYTOKINES AND TYPE III INTERFERONS, RESULTING IN IFN-γ-MEDIATED SUPPRESSION OF HCV IN VITRO by Broring, R, Lutterbeck, M, Kleinehr, K, Paul, A, Gerken, G, Schlaak, J.F

Get full text

P151 HEPADNAVIRAL REPLICATION IN HBV-TRANSGENIC MICE LACKING THE SURFACE ANTIGEN IS ACCOMPANIED BY TOLL-LIKE RECEPTOR 3 MEDIATED INTERFERON RESPONSES by Real, C.I, Broering, R, Jahn-Hofmann, K, Ickenstein, L, John, M, Kleinehr, K, Driftmann, S, Lutterbeck, M, Kemper, T, Vornlocher, H.-P, Schirmbeck, R, Lu, M, Gerken, G, Schlaak, J.F

Get full text

348 TOLL-LIKE RECEPTOR 3 STIMULATED PRIMARY HUMAN NON-PARENCHYMAL LIVER CELLS ARE POTENT SUPPRESSORS OF HEPATITIS C VIRUS REPLICATION by Lutterbeck, M, Broering, R, Kleinehr, K, Paul, A, Guido, G, Schlaak, J.F

Get full text

Long‐term stimulation of T oll‐like receptor 3 in primary human hepatocytes leads to sensitization for antiviral responses induced by poly I : C treatment by Broering, R., Lutterbeck, M., Trippler, M., Kleinehr, K., Poggenpohl, L., Paul, A., Gerken, G., Schlaak, J. F.

“…Summary Chronic hepatitis C infection is associated with increased expression of interferon‐sensitive genes ( ISGs ) in the liver, which is, paradoxically,…”
Get full text

Acetylcholinesterase activity in suction biopsies of the rectum in the diagnosis of Hirschsprung's disease by Meier-Ruge, W, Lutterbeck, P M, Herzog, B, Morger, R, Moser, R, Schärli, A

Get more information

Treatment of Non-puerperal Galactorrhoea with an Ergot Alkaloid by Lutterbeck, P. M., Pryor, J. S., Varga, L., Wenner, R.

“…Three patients suffering from non-puerperal galactorrhoea over periods ranging from two months to six years were treated with an ergot alkaloid,…”
Get full text

Post-transplantation malignancy by Lutterbeck, P M

Get more information

Suppression of Puerperal Lactation with an Ergot Alkaloid: A Double-blind Study by Varga, L., Lutterbeck, P. M., Pryor, J. S., Wenner, R., Erb, H.

“…A double-blind trial was performed in 60 women to establish the effectiveness of an ergot alkaloid, 2-Br-alpha-ergocryptine (ergocryptine; CB 154), in…”
Get full text

Measurement of analgesic activity in man by Lutterbeck, P M, Triay, S H

Get more information

Digoxin by Lutterbeck, P M, Levy, R H, Lindenbaum, J, Mellow, M H, Blackstone, M O, Butler, Jr, V P

Get more information

Localization of renal damage following Polybrene medication. Experimental study by Lutterbeck, P M, Gloor, F, Meier-Ruge, W, Yasargil, E C

Get more information

Growth of hypophysectomized patients by Lutterbeck, P M

Get more information

Enhancement of uricosuric properties of indacrinone by manipulation of the enantiomer ratio by Tobert, J A, Cirillo, V J, Hitzenberger, G, James, I, Pryor, J, Cook, T, Buntinx, A, Holmes, I B, Lutterbeck, P M

“…Racemic indacrinone is a high-ceiling, relatively long-acting diuretic. Both enantiomers have uricosuric activity, but the diuretic activity resides…”
Get more information

A double‐blind comparison of a novel indanone diuretic (MK‐196) with hydrochlorothiazide in the treatment of essential hypertension by Wilhelmsson, CE, Vedin, JA, Moerlin, C, Lund‐Johansen, P, Vorburger, C, Enenkel, W, Lutterbeck, PM, Bolognese, J, Cirillo, VJ, Tempero, KF

“…1 The antihypertensive effect and tolerability of MK‐196 (10 mg and 15 mg daily) was compared to hydrochlorothiazide (HCT; 50 mg daily) in a 4‐ week…”
Get full text